Company news

Aju Ib Investment Co., Ltd. (KRX:027360) news

Aju Ib Investment Co., Ltd. news releases on 6ix. Latest, Jul 14, 2025: Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing…

View Aju Ib Investment Co., Ltd. →

Press releases & updates

Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

July 14, 2025